CLINICOIN TOKEN SALE — TERMS AND CONDITIONS

Clinicoin Initial Participation: Terms and Conditions (Terms of Purchase of Clinicoin Cryptographic Tokens).

The sale and purchase of Clinicoin cryptographic tokens ("Clinicoin Tokens") to participants of the initial participation (together referred to as the "Holders" and individually as the "Holder") shall be subject to the terms and under the conditions set forth below ("Terms and Conditions").

The Terms and Conditions address the initial participation during which the Clinicoin Token is purchased. The initial participation of the Clinicoin Token is not and shall not be deemed to be an investment proposal and, while the Clinicoin Token is a utility digital asset that enables an end user to experience any of a number of use cases on the Clinicoin digital platform, the initial participation is not and shall not be deemed to be an offer to purchase, sell or otherwise transact securities in any jurisdiction, and the Clinicoin Token is not and shall not be deemed to be a security. Any appreciation in value of the Clinicoin Token at any time is neither intended nor a part of the Clinicoin model and would be only incidental to the Clinicoin Token's instantiation from token genesis as a utility token in the form of software code. Clinicoin Tokens are not and as all not be deemed to be monetary units nor other means of payment, store of value or unit of accounting in the understanding of the relevant legislation, common law or administrative law, and can be used for payment only inside applications, use cases, activities and services that support transactions using the Clinicoin Token. Individuals, legal entities and other organizations should carefully assess the risks, costs and benefits of acquiring and/or possessing Clinicoin Tokens at the beginning of the initial participation, compared to the expectation of acquiring Clinicoin Tokens in open markets after the initial participation is completed.

Possession of the Clinicoin Token will allow access to the Clinicoin ecosystem, including specific use cases with the Clinicoin ecosystem. Mosio, Inc., a California corporation with offices at 115 N. 85 Street, Suite 202, Seattle, WA 98103 (the "Company") still remains the sole and full right owner of the Clinicoin ecosystem. The term "Clinicoin ecosystem" shall be understood to be a set of organizational, technical, software, hardware and resources and an auxiliary infrastructure combined to ensure the smooth operation of use cases with respect to the Clinicoin ecosystem. The Holders shall have a reasonable expectation to participate in the Clinicoin Telegram channel, subject to Clinicoin terms and conditions and subject further to the Company's right to remove any individual, entity or party from the Clinicoin Telegram channel if the Company deems any expression and/or conduct to be inconsistent with Clinicoin's policies, values or mission.

By participating in the initial participation of Clinicoin, you unambiguously acknowledge, confirm, represent, warrant and covenant that you have carefully studied these Terms and Conditions, fully understand the risks, costs and benefits of acquiring the Clinicoin Token and agree to observe and comply with these Terms and Conditions. In addition, you acknowledge that the Clinicoin ecosystem team ("Project Team") will act as an authorized recipient and holder of the funds contributed as a result of the initial participation, acting as an independent autonomous community of people united by the overall goal of developing the Clinicoin ecosystem; information regarding members of the Clinicoin team is available for review on the official website of the Clinicoin ecosystem https://Clinicoin.io/ ("Website"). Solely for the purposes of more easily understanding of the contents of these Terms and Conditions, the Company and the Project Team, when they are relevantly mentioned, within the general framework are together referred to as "we" or "our".

As indicated below, you confirm, represent, warrant and covenant that, to the extent permitted by law, you have the necessary rights to purchase and/or possess the Clinicoin Token in all jurisdictions to which you are subject, that you have reached the statutory age for the purchase of the Clinicoin Token in order to be bound by these Terms and Conditions, and that you will not hold liable the Project Team (neither as a whole nor any individual members of the Project Team), the Company, affiliated companies, parents, subsidiaries, affiliates, partner companies and related companies, owners, members, shareholders, directors, officers, managers, employees, contractors, agents, and/or advisors of the Company for any damages, including special, incidental, direct, indirect or consequential damages of any kind (including legal and any other costs) arising out of, associated with or related to (directly or indirectly) the sale, purchase, transfer, acquisition and/or possession of the Clinicoin Token at present or in the future.

NOTE: WE RECOMMEND THAT YOU DO NOT ACQUIRE, PURCHASE AND/OR POSSESS THE CLINICOIN TOKEN IF YOU DO NOT HAVE EXPERT KNOWLEDGE IN THE FIELD OF SMART CONTRACTS, DECENTRALIZED APPLICATIONS, CONSENSUS ALGORITHMS, CRYPTOGRAPHIC HASH FUNCTIONS, DIGITAL ASSETS, CRYPTOGRAPHIC TOKENS AND SYSTEMS BASED ON THE SOFTWARE FUNCTIONING WITH THE SUPPORT OF BLOCKCHAIN TECHNOLOGY.

Only individuals, legal entities and other organizations with significant experience in using and understanding of the operating environment of smart contracts, decentralized applications, consensus algorithms, cryptographic hash functions, digital assets, cryptographic tokens and systems based on the software functioning with the support of blockchain technology should carry out the purchase, acquisition, transfer, sale and/or possession of the Clinicoin Token. The Holders should have a functional understanding of the mechanisms for safely storing tokens and performing transactions associated with other cryptographic tokens.

The Project Team will be available to assist the Holders during and after the initial participation, but the Project Team will not be liable for lost consideration (e.g., ETH, BTC, LTC, XRP, wire transfer and credit card or Clinicoin Tokens) as a result of actions taken by the Holders, or as a result of the failure of the Holders to take the necessary or appropriate action. Please note in particular that a Holder should exercise extra care and highest discretion in keeping the password to her or his wallet and not lose it in order to be sure that the Holder will be able to access her or his Clinicoin Tokens when they become available after the initial participation. If you do not have such experience or knowledge, you should withdraw from acquiring the Clinicoin Token and not participate in the Clinicoin initial participation.

NOTE: CRYPTOGRAPHIC TOKENS ARE SUBJECT TO EXTREME COST VOLATILITY.

Clinicoin does not imply any formal or legally binding investment nor expected appreciation in value of the Clinicoin Token at any time now or in the future. Cryptographic tokens that can be evaluated in public markets, such as BTC, can regularly exhibit acute price fluctuations in short periods. The Holder should be prepared to expect similar fluctuations with respect to the Clinicoin Token, especially with respect to decreases in value, expressed in BTC, ETH, LTC or other currencies available in open markets in the respective jurisdictions, as well as relative to values of government issued fiat currencies. Such fluctuations are caused by the common factors of open markets operation and represent changes in the balance of supply and demand. Such fluctuations can also be caused by factors that are difficult or impossible to discern, or by no factors whatsoever.

The Company cannot and does not guarantee, represent, warrant or covenant the liquidity of any market for the Clinicoin Token nor the value, price, or demand with respect to the Clinicoin Token. The Company emphasizes, and you acknowledge, that there may be frequent and protracted periods of time during which the Clinicoin Token is difficult to buy and/or sell. Moreover, there may be frequent and protracted periods during which the Clinicoin Token can be purchased or sold, but not at the price desired or sought by the Holder and/or any party seeking to purchase or sell a Clinicoin Token. In addition, due to variances in demand from one geography to another, various regulatory requirements in different jurisdictions and the inability of citizens and/or subjects of some countries to open accounts on asset exchanges located anywhere in the world, the liquidity of the Clinicoin Token may vary significantly in different geographies, and this is likely to manifest as a significant inconsistency in the price of the Clinicoin Token from one geography to another. By purchasing and/or possessing the Clinicoin Token, you unambiguously acknowledge and declare that you fully understand that Clinicoin can exhibit high, turbulent and unwelcome price volatility and that you will not attempt to nor actually assign culpability, responsibility and/or liability nor bring or file any claims, actions and/or suits against nor make any disparaging remarks regarding the Project Team (neither as a whole nor any individual members of the Project Team), the Company, affiliated companies, parents, subsidiaries, affiliates, partner companies and related companies, owners, members, shareholders, directors, officers, managers, employees, contractors, agents, and/or advisors of the Company for any losses or special, incidental, direct, indirect or incidental damages of any kind arising out of, relating to or otherwise associated with Clinicoin or the Clinicoin Token.

PRIOR TO PURCHASING, ACQUIRING AND/OR POSSESSING THE CLINICOIN TOKEN, IT IS NECESSARY TO TAKE AN ASSESSMENT OF A RANGE OF RISKS.

The purchase, acquisition and/or possession of the Clinicoin Token involves numerous risks. Prior to buying, acquiring and/or possessing the Clinicoin Token, you should carefully consider the risks described below (as well as others) and, if necessary, consult an appropriate lawyer, financial advisor, technology subject matter expert, accountant and/or tax specialist. If any risks associated with the Clinicoin Token are unacceptable, unwelcome or prohibitive for you, you should refrain from purchasing, acquiring and/or possessing the Clinicoin Token, and you should not associate with Clinicoin in any manner whatsoever. By purchasing, acquiring and/or possessing the Clinicoin Token and to the extent permitted by law, you represent, warrant and covenant that you will not hold the Project Team, the Company, affiliated companies, parents, subsidiaries, affiliates, partner companies and related companies, owners, members, shareholders, directors, officers, managers, employees, contractors, agents, and/or advisors of the Company responsible for any losses or special, incidental, direct, indirect or incidental damages of any kind arising, from relating to or otherwise associated with Clinicoin and/or the Clinicoin Token.

A BRIEF DESCRIPTION OF THE CLINICOIN INITIAL PARTICIPATION.

An event will occur during which a certain amount of Clinicoin Tokens will be made available for sale and carried out on the website ("Initial Participation"). Participants in the Initial Participation who acquire and/or possess a Clinicoin Token(s) will receive such Clinicoin Token(s) in exchange for BTC, LTC, ETH, XRP, US Dollar (wire transfer, possibly ACH, and credit card payment) and potentially other cryptocurrencies, at the price effective at the time of transfer and acquisition. For the sake of clarity, the Project Team will set an exchange rate, and the system will enable the Project Team to adjust the amount of Clinicoin Tokens per currency based on the currency value at the time the Company receives the associated currency.

The Clinicoin Token will be created in the Ethereum blockchain and will be stored on the Holder's wallet in a smart contract.

The transfer of purchased Clinicoin Tokens will be made to the relevant account of the Holder on the Website, giving each Holder control over the Clinicoin Tokens acquired by the Holder from and after the effective time of transfer. The transaction for the purchase of Clinicoin Tokens initiated by the Holder during the Initial Participation will deemed to be successfully completed when the designated number of Clinicoin Tokens are received by the Holder and the designated amount of corresponding contribution has been received by Clinicoin.

CONDUCTING OF INTIAL SALE.

The Initial Participation is divided into phases, the information regarding the precise time of beginning and completion of which is set forth on the Website.

The Company reserves the right to modify the start date of the Initial Participation and further reserves the right to extend or shorten the duration of the Initial Participation at its sole discretion, including the inaccessibility of the Website. Any force majeure circumstances that may affect or impact the Initial Participation might result in an extension, shortening or cancellation of the Initial Participation.

COST OF CLINICOIN.

The amount of accrued bonuses and discounts relating to the Initial Participation will be established depending on the then-current stage of the Initial Participation and the current bonus or discount at the time a Clinicoin Token purchase order is placed. Complete information on the Initial Participation phases, Clinicoin pricing and available bonuses will be provided in a timely manner during the Initial Participation and will be available on appropriate communication channels and/or the Website at the time of purchase. The Project Team reserves the right to update bonuses and discounts at their discretion.

DISCLOSURE OF SALES INFORMATION.

The Project Team will disclose the total amount collected during the Initial Participation in a timely manner to provide paying participants with a full understanding of the existing funding pool during the purchase of Clinicoin Tokens.

PURCHASE OF CLINICOIN ON THE WEBSITE.

The Project Team will support the Website interface, which can be used to purchase and store Clinicoin Tokens during the Initial Participation in order to ensure responsible and safe possession of Clinicoin Tokens. Instructions for purchase of Clinicoin Tokens using the Website interface will be made available for viewing on the Website during the Initial Participation period. Non-observance of and/or noncompliance with these instructions may limit, delay and/or impede the participant's purchase, acquisition and//or possession of Clinicoin Tokens. Any questions about these instructions shall be sent to [email protected]

DETERMINATION OF THE SUFFICIENCY OF THE RIGHTS OF THE HOLDER FOR THE PURCHASE OF CLINICOIN IN THE JURISDICTION OF THE HOLDER.

The Initial Participation is the transfer of a digital code accomplished in accordance with controlling legislation of the European Union. Clinicoin Tokens are utility digital code used to access the Clinicoin ecosystem, possession of which enables Holders the ability to experience certain use cases in any permitted way, not prohibited by applicable law and Clinicoin ecosystem policies, and in accordance with the generally accepted classification of cryptographic tokens as the "utility token" type. Each potential Holder is responsible for determining whether the jurisdiction to which the Holder is subject permits the purchase, acquisition and/or possession of the Clinicoin Token.

If, during the Initial Participation period, reliable evidence supporting insufficiency of the Holder's eligibility to purchase, acquire and/or possess Clinicoin Tokens and/or the Holder's violation of or noncompliance with these Terms and Conditions (including the Holder's noncompliance with restrictions and prohibitions on the purchase of software, digital assets and/or cryptocurrencies established by the legislation of the jurisdiction to which Holder is subject) is established, then the Company, acting on behalf of the development of Clinicoin ecosystem and in full compliance with the requirements of all applicable legislation, common law and administrative law of the relevant jurisdiction, will allow the possibility of access to and use of Clinicoin and the Clinicoin Token by such a Holder only after confirmation as to the existence of sufficient rights to purchase, acquire and/or possess the Clinicoin Token, along with elimination of all circumstances that resulted in actual, anticipated or potential violation of or noncompliance with the requirements of these Terms and Conditions. If the Holder refuses to remedy such violations, noncompliance and/or eligibility failures (and/or comply with all of the Company's requirements within a reasonable time), then at Company's sole discretion, all Clinicoin Tokens allocated to such Holder will be kept in special reserve by the Company without limit of time until the requisite compliance and eligibility obtains. The Holder may waive her or his eligibility to purchase, acquire and/or possess Clinicoin Tokens at any time, whereupon possession and ownership of the applicable amount of Clinicoin Tokens allocated to Holder shall revert to the Company. Please note that Clinicoin, held in reserve by Company or any designated third party pursuant to these Terms and Conditions or for any other reason, is not nor shall be deemed to be cash, currency and/or legal tender in the understanding established by the applicable law and no interest shall be charged on them. For the entire period of storage of Clinicoin, to the extent permitted by applicable law, the Holder represents, warrants and covenants that the older will not to hold the Project Team (as the whole or individual members of the Project Team), the Company, affiliated companies, subsidiaries, partners and related companies, employees, directors, employees and/or advisors of the Company responsible, culpable or liable for any losses or special, incidental, direct, indirect or incidental damages of any kind arising out of, relating to or otherwise associated with Clinicoin and/or the purchase, acquisition, possession and/or sale of Clinicoin Tokens.

ACCEPTANCE OF THE CLINICOIN TERMS OF USE.

By placing an order for the acquisition of Clinicoin, the Holder: (i) accepts and agrees to these Terms and Conditions; (ii) confirms, represents, warrants and covenants that the Holder is legally authorized and eligible to purchase Clinicoin Tokens in the jurisdiction to which the Holder is subject; (iii) confirms, represents, warrants and covenants that the Holder is of sufficient age established by law in the jurisdiction of the Holder to purchase, acquire and/or possess Clinicoin Tokens; (iv) confirms, represents, warrants and covenants that the Holder will be solely and fully responsible for any restrictions and risks associated with the acquisition of Clinicoin Tokens, as set forth below; (v) confirms, represents, warrants and covenants that the Holder has experience in using and full understanding of the operating environment of digital assets, software code, cryptographic tokens and software systems based on blockchain technology; (vi) confirms, represents, warrants and covenants that the Holder is not a citizen, resident or subject (and is not located in the territory) of any jurisdiction (including but not limited to autonomous territories) in which activities related to initial coin offerings, token sales and/or operations with respect to cryptocurrencies are prohibited or require special authorizations.

Independent Confirmation of the Clinicoin Purchase.

During the process of making Clinicoin Token purchases and/or acquisitions on the Website, the Project Team will provide the Holders with a unique intermediate crypto-address. Using this address, the Holders may monitor and confirm that the Holder's cryptocurrency was received at this address. Knowledge of a unique intermediate address does not constitute nor shall be deemed to be a receipt for purchase and does not indicate in any way that any party with such knowledge has ownership and/or possession with respect to Clinicoin Tokens.

Email for the Purchase of Clinicoin

The Holder shall provide an email address ("Email") to make an order as part of the process of purchasing and/or acquiring Clinicoin Tokens. The Email specified by the Holder will be used to send notification on the creation of the Holder's account on the Website. By purchasing, acquiring and/or possessing Clinicoin Tokens, to the extent permitted by applicable law, the Holder represents, warrants and covenants that the older will not to hold the Project Team (as the whole or individual members of the Project Team), the Company, affiliated companies, subsidiaries, partners and related companies, employees, directors, employees and/or advisors of the Company responsible, culpable or liable for any losses or special, incidental, direct, indirect or incidental damages of any kind arising out of, relating to or otherwise associated with the inability of the Holder to secure her or his account.

Purchase of Clinicoin during the Initial Participation is Available Exclusively through the Website.

The purchase and/or acquisition of Clinicoin Tokens is available only through the Website, available at the web address https://Clinicoin.io. If any third party website or service offers or proposes to purchase, acquire and/or sell Clinicoin Tokens at the time of the Initial Participation, or otherwise ensures the sale and/or transfer of Clinicoin Tokens in any way during the Initial Participation, we expressly inform you that we have not permitted such third party websites or services to perform similar operations and they no association whatsoever with the Initial Participation, the Clinicoin ecosystem, the Project Team or the Company. We expressly and positively prohibit the use of these such third party websites or services to purchase, acquire and/or sell Clinicoin Tokens prior to the completion of the Initial Sale.

Fraudulent Double-Spending.

The Project Team will monitor all potential transactions in an attempt to prevent fraudulent double-spending. Any revealed fraudulent double-spending will result in a denial of Clinicoin Token transfer to the associated party.

Possible Storage.

Clinicoin Tokens will be stored in a wallet that can be accessed only by using a password selected by the Holder. Holders must safely store their password and secret recovery information in one or more backup locations separately from the primary storage location of the password. If the Holder does not keep her or his password and secret recovery information responsibly in order to prevent loss and/or compromise, then all associated Clinicoin Tokens can be lost or stolen.

Any third party that has access to the Email can access the information sent to the Holder, which may include important information about the ownership of associated Clinicoin Tokens. The Holder must take care not to respond to any inquiries related to the purchase of Clinicoin Tokens, including but not limited to letters and inquiries allegedly received by email from a website or similar domain. Emails ostensibly received from the Project Team, Clinicoin admin or any other division associated with Clinicoin should be verified for authenticity by examining the associated SSL insignia.

Cryptocurrencies remain subject to regulatory control by various regulatory bodies around the world. One or more regulatory requirements or regulations that may interfere with or limit the ability to continue development of the Clinicoin ecosystem can influence the Clinicoin ecosystem, the Project Team and/or the Company.

It is possible that not a large number of Holders will use the Clinicoin Token as the internal currency of the Clinicoin ecosystem, and that there will be limited public interest in using the capabilities of the Clinicoin ecosystem. This lack of interest can affect the development of the Clinicoin ecosystem. The Project Team cannot predict the success of its marketing efforts nor the efforts of other third parties. There are no guarantees of utility, income, appreciation or profit associated with Clinicoin, the Clinicoin Token nor the development of the ecosystem in accordance with the approved roadmap.

The Holder acknowledges that the Clinicoin ecosystem is currently in development and may undergo significant changes in the future. The Holder acknowledges that any expectations regarding the form and functionality of the Clinicoin ecosystem may not be justified for any number of reasons, including a change in the development strategy and priorities for the development of the Clinicoin ecosystem.

The Holder understands and acknowledges that, even though the Project Team will make reasonable efforts to develop the Clinicoin ecosystem, it is possible that the Clinicoin ecosystem will not be created and/or not grow and develop, and perhaps all or part of the use cases and associated transactions using the Clinicoin Token will no longer be available to the Holders.

Hackers or other groups or organizations may attempt to steal or otherwise improperly take possession of funds contributed during the Initial Participation period, which could potentially affect the ability of the Project Team and the Company to develop the Clinicoin ecosystem. In the context of this risk, the Project Team and the Company accept and will continue to take comprehensive reasonable precautions to protect funds contributed during the Initial Participation Period. Multifactor security measures will be taken to protect the contributed funds and the Clinicoin Tokens, including, among other things, physical elements, keys with multi-signatures, divided storage of funds, separation into "hot"/"cold" wallets and diversification. Moreover, security checks of "hot" and "cold" wallets and the appropriate measures to reduce risks will be conducted on a regular basis.

Current advances in code hacking techniques and technological advances, such as the development of quantum computers, can pose risks to the Clinicoin cryptocurrency and ecosystems, which can lead to theft or loss of Clinicoin Tokens. To the extent possible, the Project Team and the Company intend to take the appropriate measures to protect the code behind the Clinicoin ecosystem, taking into account the available advances in cryptography and the implementation of additional security measures, but cannot guarantee the success of any future security updates.

The loss or destruction of important Clinicoin ecosystem data resulting from the hacking of the code behind the Clinicoin ecosystem may be irreversible, which can adversely affect the cost of Clinicoin.

As in the case of other cryptocurrencies, the blockchain used in the operation of the Clinicoin ecosystem is susceptible to attacks. Any successful attacks pose a threat to the Clinicoin ecosystem and the accuracy of transactions with payments.

Clinicoin is a new platform, and the level of interest of Holders and the public may affect the price of Clinicoin Tokens in open markets. Factors affecting the further development of the digital assets industry, as well as the Clinicoin ecosystem, include:

a. continued worldwide growth in the introduction and use of the Clinicoin Token and other digital assets;

b. state and quasi-public regulation of the Clinicoin Token and other digital assets, their use or prohibition of use, regulation of access to software products supporting transactions using Clinicoin, or their operation;

c. support and development of Clinicoin ecosystem software;

d. changes in consumer demography, general trends and preferences;

e. availability and popularity of competitors' products; and

f. general economic conditions and the regulatory environment that affect the Clinicoin ecosystem and digital assets.

Claims related to intellectual property rights may adversely affect the operation of the Clinicoin ecosystem. Third parties may attempt to bring claims with respect to alleged intellectual property rights related to the storage and transfer of digital assets and their source code. Regardless of the possible frivolity or mendacity of such legal actions, claim or allegation that reduces the credibility of the long-term liveness of the Clinicoin ecosystem or the ability of the Holders to access, store, sell and/or use their Clinicoin Tokens in any use case of the Clinicoin ecosystem it may adversely affect the price of the Clinicoin Token. In addition, claims relating to intellectual property rights may prevent the Holders from gaining access to the Clinicoin ecosystem or the ability of the Holders to retain access to, store, use and/or sell their Clinicoin Token.

Crypto exchange services on which the Clinicoin Token can be traded can be relatively new and rather unregulated and therefore may be more susceptible to fraud, tampering and/or malfunction than the long-running and regulated crypto exchange services. To the extent that cryptocurrency exchange services that provide a significant part of the Clinicoin Token trading volume are fraudulent, tampered with and/or have security problems or other operational problems, such interruptions in the operation of cryptocurrency exchange services can lead to reduced prices for and a negative impact on the value of the Clinicoin Token. The lack of stability in the operation of cryptocurrency exchange services, the closing or suspension of an exchange of cryptocurrency services due to fraud, tampering, operation failure, hacker or malicious program interference and/or government-sanctioned regulation may reduce the credibility of the Clinicoin ecosystem and lead to greater Clinicoin Token price volatility.

Political or economic crises can lead to the sale of substantial volumes of Clinicoin Tokens, which can lead to lower prices of and a negative impact on the value of Clinicoin Tokens. Digital assets, such as the Clinicoin Token, which are relatively new, are subject to increased supply and demand effects based on the popularity of alternative digital assets, speculative expectations and/or fluctuations in the demand for decentralized funds for payments for use cases in the Clinicoin ecosystem, and it is not known how geopolitical events will influence such factors. Sales of large volumes of Clinicoin Tokens will lead to a decrease in the price or value of Clinicoin Tokens.

It is possible that a digital asset other than the Clinicoin Token may have properties that make it more desirable to purchase, acquire, possess and/or use, which can result in a decrease in the demand for Clinicoin Tokens, which could, in turn, adversely affect utilization capacity and the price or value of the Clinicoin Token. There is a possibility that the alternative digital asset can become significantly more popular due to the supposed or disclosed shortcomings of the Clinicoin ecosystem that cannot be eliminated by the reasonable efforts of the Project Team and/or the Company at the desired time, or it might be decided not to eliminate the shortcomings. If the alternative digital asset were to capture a significant market share, the demand for and/or price or value of Clinicoin Tokens could be reduced.

Cryptocurrency transactions cannot be reversible, from the administrative point of view, without the consent and active participation of the recipient of the transaction or, theoretically, monitored or agreed upon by the majority of computing power in the ecosystem blockchain. Operations with respect to Clinicoin Tokens are irrevocable and, accordingly, stolen or incorrectly translated Clinicoin Tokens may be irretrievably lost. After such a transaction has been confirmed and recorded in the blockchain, the operation with the incorrect Clinicoin Token transfer or Clinicoin Token theft will not be reversible and there can be no compensation for such transfer or theft. Such losses can adversely affect the price or value of Clinicoin Tokens.

Clinicoin Tokens will be released on the Ethereum blockchain. Thus, any malfunction or unforeseen operation of the Ethereum protocol can affect the ability of the Holder to transfer, sell, use or safely store Clinicoin Tokens. Such an impact can adversely affect the cost or value Clinicoin Tokens.

It is possible that, for numerous reasons, including but not limited to the deterioration of business relationships or marketing strategies, the Clinicoin ecosystem and all associated marketing may not be successful due to a shortage of contribution with respect to the Initial Participation.

Prohibition on Participation in the Initial Participation.

Some jurisdictions prohibit or restrict the conduct of token sales, token generating events, ICOs, other similar fund-raising models and/or cryptocurrency transactions. In the interests of stable development of the Clinicoin ecosystem, we decided to restrict certain categories of individuals from purchasing, acquiring and/or possessing Clinicoin Tokens during the Initial Participation period.

All Purchased Clinicoin Tokens are Nonrefundable.

ALL COMPLETED PURCHASES OF CLINICOIN TOKENS ARE FINAL, AND THE RETURN OF ASSOCIATED FUNDS IS DISALLOWED. BY THE PURCHASE OF CLINICOIN TOKENS, THE HOLDER CONFIRMS THAT SHE OR HE IS AWARE OF THE ABSENCE OF THE RIGHT OF REFUND FOR ANY REASONS AND THAT THE PROJECT TEAM, THE COMPANY AND ANY OTHER PARTIES HAVE NO OBLIGATIONS OR LIABILITY WITH RESPECT TO THE HOLDER FOR REFUND OR FOR ANY REASON, AND THAT THE HOLDER WILL NOT RECEIVE MONEY OR COMPENSATION OF ANY OTHER KIND IF THE CLINICOIN TOKEN CANNOT BE USED OR REMAINS UNUSED.

Taxation of Clinicoin and Taxation of Income Received during the Period of Initial Participation.

Neither the Project Team nor the Company provides nor shall be expected to provide any professional, financial or legal advice with respect to the tax consequences of purchasing, acquiring, possessing and/or or using a Clinicoin Token. Depending on the requirements of the applicable legislation, common law and administrative law in the jurisdiction to which the Holder is subject, transactions related to the purchase, acquisition, possession or use of Clinicoin may result in tax liabilities for the Holder at the time of Clinicoin Token purchase and/or in the future. The Holder is fully responsible for determining whether the purchase, acquisition, possession and/or use of the Clinicoin Token, and/or the potential increase or decrease in the price or value of the Clinicoin Token over time, have tax consequences within the jurisdiction to which the Holder is subject. By purchasing, acquiring, possessing and/or using the Clinicoin Token (to the extent permitted by law), the Holder represents, warrants and covenants that the older will not to hold the Project Team (as the whole or individual members of the Project Team), the Company, affiliated companies, subsidiaries, partners and related companies, employees, directors, employees and/or advisors of the Company responsible, culpable or liable for any losses or special, incidental, direct, indirect or incidental damages of any kind arising out of, relating to or otherwise associated with any taxes due from the Holder related to the purchase, acquisition, possession and/or and use of the Clinicoin Token.

Privacy.

In spite of the fact that the Holder's email address is required, neither the Project Team nor the Company shall publish any identifying information related to the purchase, acquisition possession and/or use of associated Clinicoin Tokens without the prior, written consent of the Holder.

AML/KYC Policies.

If at any time, in order to comply with current applicable laws, regulations or recommendations in any jurisdiction, we require that a participant(s), Holder or all Holders provide additional information about themselves and/or any associated transactions that are being or might be undertaken, then we will request from such participant(s) and Holder(s) information regarding suspicious activity relating to transactions and/or settlements. We may also require such participant(s) and/or Holder(s) to provide additional information as required by legislation, common law or administrative law in any jurisdictions, including but not limited to information relating to suspicious transactions in an amount equivalent to Two Thousand Dollars (US$2,000) or greater.

We adhere to the policy of KYC (Know Your Customer) and AML (Anti-Money Laundering) in order to comply with documentation requirements. We aspire, in necessary cases and within reasonable limits, to identify each participant and each Holder by cross-verification of the participant's or Holder's data in accordance with government observatory lists, including the possibility of using third-party verification and authentication services. If the proposed transaction for the purchase of Clinicoin Tokens requires additional verification, then we may require additional evidence of identification from the participant or Holder, and we are entitled not to authorize any participant's or Holder's purchases, acquisitions and/or possessions of Clinicoin Tokens until the participant or Holder provides an additional verifiable identity authentication for our check. Based on the results of the verification, we may approve or refuse at our discretion the transaction for the purchase and/or acquisition of the Clinicoin Token.

By accepting these Terms and Conditions, the participant and/or Holder acknowledges and agrees that:

a. we maintain a level of verification that requires the cooperation of participants and/or Holders and the verification of the possibility of obtaining our permission to purchase Clinicoin Tokens on the basis of information provided by the participants and/or Holders, our ability to verify the participants and/or Holders and compliance with our internal policies;

b. the participant and/or Holder may not be able to achieve the desired level of verification and approval for the purchase of Clinicoin Tokens;

c. we reserve the right, in our sole discretion, to determine the appropriate level of verification for each participant and/or Holder, as well as the right to refuse the approval of the purchase of Clinicoin Tokens at our own discretion and without giving reasons;

d. we may from time to time adhere to policies that limit the levels of verification by nationality, country of residence or any other factor that might affect the right of the participant and/or Holder to purchase Clinicoin Tokens;

e. the participants and/or Holders shall not hold the Project Team (the whole or individual members of the Project Team), the Company, affiliated companies, subsidiaries, partner companies and related companies, directors, employees and/or advisors of the Company liable for any damages, including special, incidental, direct, indirect or related damages of any kind (including legal and any other costs) arising from or related to verification results (arising from a refusal to approve the purchase of Clinicoin Tokens, or the approval of the purchase of Clinicoin Tokens) now or in the future;

f. we reserve the right to reject payment for the purpose of the Clinicoin Token purchasing from any potential participant and/or Holder if the participant and/or Holder does not meet the AML/KYC requirements that we set or the participant and/or Holder is unable to fulfill the terms of any verification and screening procedures; and

g. we may cooperate with law enforcement agencies and, among other things, take the appropriate measures permitted by law for any suspicion of the participant's and/or Holder's use of Clinicoin Tokens or participating in the sale of Clinicoin Tokens for any criminal purpose, including money laundering.

To prevent the use of the Clinicoin Token or the Clinicoin ecosystem for any criminal purpose, including money laundering and/or financing of terrorism, we may require the participants and/or Holders to provide at least the following information:

a. name and surname of the participant and/or Holder;

b. a photograph of a passport or other equivalent document for the identification of the participant and/or Holder;

c. documents confirming the address of residence/registration of the participant and/or Holder;

d. proof of participant's and/or Holder's ownership of the Email address;

e. contact number of the participant and/or Holder; and/or

f. documents proving the participant's and/or Holder's sufficient level of professional knowledge in the field of software code, smart contracts, decentralized applications, digital assets, cryptographic tokens, investments, and/or systems based on blockchain supported technology.

We may request both fully and partially specified information and documents, as well as require the provision of additional information at our own discretion.

Disclaimer of Warranties.

THE PARTICIPANT AND/OR HOLDER UNAMBIGUOUSLY ACKNOWLEDGES AND AGREES THAT THE PARTICIPANT AND/OR HOLDER PURCHASES CLINICOIN TOKENSAT HER OR HIS OWN RISK AND THAT POSSESSION OF THE CLINICOIN TOKEN IS TRANSFERRED ON THE TERMS "AS IS" WITHOUT ANY GUARANTEE, NEITHER EXPRESS NOR IMPLIED, INCLUDING, BUT NOT LIMITED TO, GUARANTEES OF OPERATIVITY OR IMPLIED GUARANTEES, OF COMMERCIAL VALUE OR FITNESS FOR A PARTICULAR PURPOSE (EXCEPT ONLY TO THE EXTENT THAT APPLICABLE LAW SETS WITHIN A WARRANTY PERIOD, BUT NOT MORE THAN THE LESSER OF: (A) THIRTY (30) DAYS FROM THE DAY OF A PURCHASE OF A CLINICOIN TOKEN, OR (B) THE MINIMUM COMPULSORY PERIOD). WITHOUT LIMITATION OF THE ABOVE, NEITHER THE PROJECT TEAM NOR THE COMPANY GUARANTEES THAT THE CLINICOIN TOKEN PURCHASE PROCESS WILL NOT BE INTERRUPTED OR BE EXECUTED WITHOUT ERRORS.

Limitations and Exclusion of Liability.

THE PARTICIPANT AND/OR HOLDER ACKNOWLEDGES AND AGREES THAT, PERMITTED BY ANY APPLICABLE LAW, EXCLUSION OF LIABILITY CONTAINED HEREIN APPLIES TO ANY DAMAGES OR LOSSES, THAT ARE CAUSED BY OR ARE RELATED TO THE USE OF OR INABILITY TO USE CLINICOIN TOKEN AND/OR CLINICOIN ECOSYSTEM FOR ANY REASON OR CIRCUMSTANCE, IN ANY KIND IN ANY JURISDICTION, INCLUDING, WITHOUT LIMITATION, BREACH OF WARRANTIES, VIOLATION OF CONTRACTUAL AND VIOLATION OF NON-CONTRACTUAL OBLIGATIONS, TORTIOUS CONDUCT, AND THAT NEITHER THE PROJECT TEAM NOR THE COMPANY WILL BE LIABLE FOR ANY SPECIAL, INCIDENTAL, DIRECT, INDIRECT, OR CONSEQUENTIAL DAMAGES, INCLUDING PROFIT LOSSES, DAMAGE TO GOODWILL OR LOSS OF DATA, CAUSED IN ANY FORM IN CONNECTION WITH THE USE OR INABILITY TO USE, PURCHASE OR THE INABILITY TO PURCHASE THE CLINICOIN TOKEN. THE PARTICIPANT AND/OR HOLDER FURTHER EXPRESSLY ADMITS THAT THE PROJECT TEAM AND THE COMPANY WILL NOT BE LIABLE FOR THE BEHAVIOR OF THIRD PARTIES, INCLUDING OTHER CLINICOIN HOLDERS, AND THAT THE CLINICOIN PURCHASE RISKS FULLY REMAIN ON THE PARTICIPANT AND/OR HOLDER, TO THE EXTENT PERMITTED UNDER APPLICABLE LAW. IN NO EVENT SHALL THE PROJECT TEAM AND/OR THE COMPANY HAVE ANY LIABILITY TOWARD ANY HOLDER FOR AN AMOUNT GREATER THAN THAT PAID BY THE PARTICIPANT AND/OR HOLDER TO PURCHASE AND/OR ACQUIRE CLINICOIN TOKENS. SOME JURISDICTIONS DO NOT ALLOW THE REMOVAL OF CERTAIN WARRANTIES, LIMITATIONS, OR EXCLUSION OF LIABILITY FOR SOME DAMAGES.

Settlement of Disputes.

a. The Project Team, the Company and the participant and/or Holder (the "Parties") agree to make due efforts to resolve any disputes, claims or demands arising between them in respect of the Initial Participation and their respective rights and obligations under these Terms and Conditions ("Dispute").

b. If the Parties or their authorized representatives are unable to resolve a Dispute within thirty (30) calendar days after the referring of this matter to them, the Parties will resolve the Dispute in accordance with clause "c" of this section, below. The claim procedure for settling disputes under these Terms and Conditions is not mandatory for the Project Team and the Company.

c. All disputes arising in connection with these Terms and Conditions or related to them, which the Parties are unable to resolve through negotiations, shall be resolved through arbitration by an arbitrating entity designated by the Project Team.

22. Force Majeure Circumstances.

Neither the Project Team nor the Company shall be liable for failure to fulfill their obligations solely because of:

a. flood, fire, earthquake, accident, natural disaster,
b. delays in delivery of materials,
c. embargo,
d. strike,
e. state orders,
f. acts of civil or military authorities,
g. war, violence, unrest, activism,
h. actions of conventional carriers,
i. extreme conditions (including weather conditions), or
j. any similar unforeseen event that makes the work commercially unjustified.

In case of force majeure circumstances, the Party affected by the inability of the other Party to fulfill its obligations may decide to suspend these Terms and Conditions in whole or in part during the period of validity of force majeure circumstances. The Party facing force majeure circumstances shall cooperate with the injured party and assist it in all reasonable ways to minimize the impact of force majeure on the victim.

Full Agreement.

These Terms and Conditions establish and constitute the full understanding between each Participant and/or Holder, on the one hand, and the Project Team and/or the Company, on the other hand, with respect to the sale, purchase, acquisition, transfer, possession and/or use of the Clinicoin Token. In evidence and facts related to the purchase, acquisition, possession and/or use of the Clinicoin Token, the participant and/or Holder agrees to rely only on these Terms and Conditions when making purchase decisions and understands that these Terms and Conditions address the sale and/or transfer of Clinicoin, replacing any public Initial Participation statements made by third parties, the Project Team and/or the Company, or persons associated with the Project Team and/or the Company, in the past, now, and in the Initial Participations period. The participant and/or Holder acknowledges that there are no warranties, statements, conditions or agreements, expressed or implied, between the Parties, other than those expressly provided in these Terms and Conditions. In case of any discrepancy between any translated versions of these Terms and Conditions, the version of these Terms and Conditions in English shall prevail.

Changes.

The Project Team and/or the Company reserve the right, at their sole discretion, to modify, alter, add or delete parts of these Terms and Conditions at any time during the Initial Participation period by publishing the amended Terms and Conditions on the Website. Any participant and/or potential Holder shall be deemed to have accepted such changes to the Terms and Conditions by purchasing, acquiring, possessing and/or using a Clinicoin Token. If at any time the participant and/or potential Holder disagrees with any part of the then-current version of the Terms and Conditions, then she or he (the participant and/or Potential Holder) shall not purchase any Clinicoin Tokens.

Separability.

The participant and/or Holder agrees that if any part of these Terms and Conditions is determined by a court exercising competent jurisdiction to be illegal, invalid or unenforceable, in whole or in part, then such provision shall be invalid and unenforceable in respect of such jurisdiction solely to the extent of such determination of invalidity or unenforceability, without affecting the validity or the enforcement of any other method or jurisdiction and without affecting or limiting the remaining provisions of these Terms and Conditions, which will continue to remain in full force and effect.

Waiver of Rights.

The inability of the Project Team and/or the Company to require or enforce strict compliance with respect to any provision of these Terms and Conditions by a participant(s) and/or Holder(s) and/or failure of the Project Team and/or the Company to exercise any right under these Terms and Conditions shall not be considered as a waiver of the right of the Project Team and/or Company to any such provision or right in this or any other case. The expressed refusal of the Project Team and/or the Company to enforce any provision, condition or requirement of these Terms and Conditions shall not be deemed to be a waiver of any future obligation to comply with such provision, condition or requirement. Except as expressly and in particular set forth in these Terms and Conditions, no claims, approvals, agreements, waivers or other acts or omissions by the Project Team and/or the Company shall be deemed to be a modification of these Terms and Conditions, nor shall they have legal effect, if they are not documented in a physical letter by the associated participant and/or Holder in person and a delivered to a diligently appointed officer, representative or agent of the Project Team and/or the Company.

Cooperation with respect to Legal Requirements.

The Project Team and the Company shall cooperate in all investigations, take part in litigation and provide answers to legal requests, provided that they are fully justified and legality is confirmed by legislation in the relevant jurisdictions. The Project Team and the Company shall aspire to consider all received legal requests publicly.

Detailed Information.

For more information relating to the purchase, acquisition, possession and/or use of the Clinicoin Token, please send us message to [email protected]